Maryam Fazeli

Motamed Cancer Institute, ACECR

Title: Design and Synthesis of Oncolytic Adenovirus Encoding Hsp70 Adjuvant Fused to E6 and E7 Antigenic Sequences of Human Papillomavirus Types 16 and 18, and Investigation of its Therapeutic Effects in a Cervical Cancer Mouse Model

---

Biography

Maryam Fazeli, PhD, is a virologist specializing in oncolytic virotherapy and emerging viral diseases. She completed her PhD in Medical Virology at Modares University in 2015, focusing on the development of therapeutic DNA vaccines. Over the years, she has gained extensive expertise in viral immunology, bioinformatics, and advanced techniques such as CRISPR/Cas9 gene-editing. Currently, Dr. Fazeli is a researcher at the ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran. Her research centers on designing oncolytic adenoviruses targeting HPV-related cancers and exploring innovative therapeutic approaches for diseases like COVID-19 and rabies. She has contributed to numerous international and national projects and has published extensively in peer-reviewed journals. Teaching and mentoring are also key aspects of her career, and she is passionate about advancing the field of virology and developing novel treatments for viral-driven cancers.

Abstract